Weekly Recap | Revolution Medicines +0.81%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 07:37 AMRVMD+0.50%
Weekly Recap | Roche -4.04%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 07:34 AMRHHBY+2.89%
Weekly Recap | Lexicon Pharma +1.39%, consensus target above spotWeekly Review·Oct 3, 2026 at 07:11 AMLXRX+0.57%
